Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 28, 2024 07:30 ET | Source: Optimi Health Corp.

Optimi Announces Closing of First Tranche of Non-Brokered Private Placement

VANCOUVER, British Columbia, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a Health Canada licensed drug researcher and...
August 10, 2023 07:30 ET | Source: Optimi Health Corp.

Optimi Health Announces CAD $3,000,000 Senior Debt Financing

VANCOUVER, British Columbia, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a Canadian drug research and formulation company licensed by Health Canada...
February 22, 2022 10:34 ET | Source: Optimi Health Corp.

UPDATE - Optimi Health Launches E-Commerce Platform Featuring All-Natural Functional Mushroom Supplements

VANCOUVER, British Columbia., Feb. 22, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQB: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated mushroom...
February 22, 2022 09:00 ET | Source: Optimi Health Corp.

Optimi Health Launches E-Commerce Platform Featuring All-Natural Functional Mushroom Supplements

VANCOUVER, British Columbia., Feb. 22, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQB: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated mushroom...
February 16, 2022 09:00 ET | Source: Optimi Health Corp.

Optimi Health Approved to Supply Psilocybin Under Health Canada’s Special Access Program

VANCOUVER, British Columbia, Feb. 16, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQB: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated mushroom...
July 27, 2021 09:00 ET | Source: Optimi Health Corp.

Optimi Health Strengthens Clinical and Regulatory Expertise

VANCOUVER, British Columbia, July 27, 2021 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTC: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), as part of its strategic aim to fully investigate...
June 15, 2021 09:00 ET | Source: Optimi Health Corp.

Optimi Health Completes Pre-Clinical Trial Application Meeting

VANCOUVER, British Columbia, June 15, 2021 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTC: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a vertically integrated mushroom product developer...
June 08, 2021 09:00 ET | Source: Optimi Health Corp.

Optimi Health Announces Product Distribution Agreement with Vitasave

VANCOUVER, British Columbia, June 08, 2021 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTC: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated functional...
May 26, 2021 09:00 ET | Source: Optimi Health Corp.

Optimi Health Appoints Chief Science Officer

VANCOUVER, British Columbia, May 26, 2021 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTC: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated functional...
May 11, 2021 09:00 ET | Source: Optimi Health Corp.

Optimi Health and Numinus Wellness Submit All-Natural Psilocybin Extract to Health Canada for Pre-Clinical Trial Application

VANCOUVER, British Columbia, May 11, 2021 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTC: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated functional...

Next Page keyboard_arrow_right